[HTML] plos.org

[HTML][HTML] Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLoS …, 2017 - journals.plos.org
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …
被引用次数：42 相关文章

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase… - PloS …, 2017 - pubmed.ncbi.nlm.nih.gov
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …

[引用][C] Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLOS ONE, 2017 - cir.nii.ac.jp
Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection
fraction and hypertrophy among cardiac patients | CiNii Research CiNii 国立情報学研究所 学術 …

[引用][C] Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLoS …, 2017 - ui.adsabs.harvard.edu
Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection
fraction and hypertrophy among cardiac patients - NASA/ADS Now on home page ads icon …
[PDF] semanticscholar.org

[PDF][PDF] Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase… - PLoS …, 2017 - pdfs.semanticscholar.org
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …
[HTML] nih.gov

[HTML][HTML] Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLoS ONE, 2017 - ncbi.nlm.nih.gov
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - Plos one, 2017 - europepmc.org
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLoS ONE, 2017 - go.gale.com
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLoS …, 2017 - search.ebscohost.com
Background and purpose: Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …